As the global economy mends, the 2021 growth of Recombinant Coagulation Factor Concentrate will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Coagulation Factor Concentrate market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Coagulation Factor Concentrate market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Recombinant Coagulation Factor Concentrate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Recombinant Coagulation Factor Concentrate market, reaching US$ million by the year 2028. As for the Europe Recombinant Coagulation Factor Concentrate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Recombinant Coagulation Factor Concentrate players cover Bayer, Alprolix, Benefix, and Idelvion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Coagulation Factor Concentrate market by product type, application, key manufacturers and key regions and countries.
Segmentation by dose: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
250 IU
500 IU
1000 IU
2000 IU
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hopistial
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字（中国）生物制品有限公司